• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
In-hospital outcomes and readmission in older adults treated with percutaneous coronary intervention for stable ischemic heart disease.接受经皮冠状动脉介入治疗的老年稳定型缺血性心脏病患者的院内结局及再入院情况。
J Geriatr Cardiol. 2022 Sep 28;19(9):631-642. doi: 10.11909/j.issn.1671-5411.2022.09.006.
2
Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.稳定性缺血性心脏病、非ST段抬高型急性冠状动脉综合征和ST段抬高型心肌梗死患者复发性缺血事件的风险及发生时间。
Am Heart J. 2016 May;175:56-65. doi: 10.1016/j.ahj.2016.01.021. Epub 2016 Feb 23.
3
Temporal Trends and Outcomes of Percutaneous Coronary Interventions in Nonagenarians: A National Perspective.九十岁以上人群经皮冠状动脉介入治疗的时间趋势和结局:国家视角。
JACC Cardiovasc Interv. 2018 Sep 24;11(18):1872-1882. doi: 10.1016/j.jcin.2018.06.026.
4
Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost: Insights From the Nationwide Readmission Database.美国 833344 例经皮冠状动脉介入治疗后 30 天再入院负担:预测因素、原因和费用:来自全国再入院数据库的见解。
JACC Cardiovasc Interv. 2018 Apr 9;11(7):665-674. doi: 10.1016/j.jcin.2018.01.248.
5
Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia.澳大利亚症状性稳定型缺血性心脏病行经皮冠状动脉介入治疗患者的趋势和真实世界安全性。
Heart Lung Circ. 2022 Dec;31(12):1619-1629. doi: 10.1016/j.hlc.2022.08.019. Epub 2022 Oct 28.
6
Associations Between Hospital Length of Stay, 30-Day Readmission, and Costs in ST-Segment-Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis.ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后住院时间、30 天再入院率与费用的相关性:一项全国再入院数据库分析。
J Am Heart Assoc. 2020 Jun 2;9(11):e015503. doi: 10.1161/JAHA.119.015503. Epub 2020 May 29.
7
Clinical Outcomes of Acute Myocardial Infarction Hospitalizations With Systemic Lupus Erythematosus: An Analysis of Nationwide Readmissions Database.系统性红斑狼疮患者急性心肌梗死住院的临床结局:基于全国再入院数据库的分析
Curr Probl Cardiol. 2022 Nov;47(11):101086. doi: 10.1016/j.cpcardiol.2021.101086. Epub 2021 Dec 20.
8
Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population.比较当代美国经皮冠状动脉介入治疗患者与 ISCHEMIA 试验人群。
JACC Cardiovasc Interv. 2021 Nov 8;14(21):2344-2349. doi: 10.1016/j.jcin.2021.08.047.
9
Long-term mortality in asymptomatic patients with stable ischemic heart disease undergoing percutaneous coronary intervention.稳定型缺血性心脏病经皮冠状动脉介入治疗无症状患者的长期死亡率。
Am Heart J. 2022 Feb;244:77-85. doi: 10.1016/j.ahj.2021.10.190. Epub 2021 Nov 12.
10
Revascularization versus medical therapy in patients aged 80 and older with stable ischemic heart disease.80岁及以上稳定型缺血性心脏病患者的血运重建与药物治疗对比
J Am Geriatr Soc. 2021 Dec;69(12):3457-3467. doi: 10.1111/jgs.17404. Epub 2021 Aug 7.

引用本文的文献

1
Demographic diversity in platelet function and response to antiplatelet therapy.血小板功能及对抗血小板治疗反应中的人口统计学差异。
Trends Pharmacol Sci. 2025 Jan;46(1):78-93. doi: 10.1016/j.tips.2024.11.005. Epub 2024 Dec 12.
2
Representation of Older Adults in the ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.美国心脏病学会/美国心脏协会/心血管造影和介入学会冠状动脉血运重建指南中老年人的代表性情况。
JAMA Netw Open. 2024 Jul 1;7(7):e2421547. doi: 10.1001/jamanetworkopen.2024.21547.
3
Chronic Coronary Disease in Older Adults.老年人慢性冠状动脉疾病。
Med Clin North Am. 2024 May;108(3):581-594. doi: 10.1016/j.mcna.2023.12.004. Epub 2024 Jan 4.
4
Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.老年人经皮冠状动脉介入治疗后缩短双联抗血小板治疗:系统评价和网络荟萃分析。
JAMA Netw Open. 2024 Mar 4;7(3):e244000. doi: 10.1001/jamanetworkopen.2024.4000.
5
Assessment and Management of Older Adults Undergoing PCI, Part 1: A Expert Panel.接受经皮冠状动脉介入治疗的老年人的评估与管理,第1部分:专家小组。
JACC Adv. 2023 Jun;2(4). doi: 10.1016/j.jacadv.2023.100389.
6
The Heterogeneity of Old Age: Healthy Aging in Older Adults Undergoing TAVR.老年的异质性:接受经导管主动脉瓣置换术的老年人的健康老龄化
JACC Cardiovasc Interv. 2023 Jan 23;16(2):189-192. doi: 10.1016/j.jcin.2022.12.008.

本文引用的文献

1
Individualized Biological Age as a Predictor of Disease: Korean Genome and Epidemiology Study (KoGES) Cohort.作为疾病预测指标的个性化生物学年龄:韩国基因组与流行病学研究(KoGES)队列
J Pers Med. 2022 Mar 21;12(3):505. doi: 10.3390/jpm12030505.
2
Frailty Predicts Poor Prognosis of Patients After Percutaneous Coronary Intervention: A Meta-Analysis of Cohort Studies.衰弱预示经皮冠状动脉介入治疗后患者的不良预后:队列研究的荟萃分析
Front Med (Lausanne). 2021 Aug 19;8:696153. doi: 10.3389/fmed.2021.696153. eCollection 2021.
3
Population Trends in Rates of Percutaneous Coronary Interventions, 2010 to 2017.2010 至 2017 年经皮冠状动脉介入治疗率的人口趋势。
JAMA Cardiol. 2021 Oct 1;6(10):1219-1220. doi: 10.1001/jamacardio.2021.2639.
4
External validation of the Hospital Frailty Risk Score in France.法国的医院衰弱风险评分的外部验证。
Age Ageing. 2022 Jan 6;51(1). doi: 10.1093/ageing/afab126.
5
Utility of the Hospital Frailty Risk Score Derived From Administrative Data and the Association With Stroke Outcomes.源自行政数据的医院虚弱风险评分的效用及其与卒中结局的关联。
Stroke. 2021 Aug;52(9):2874-2881. doi: 10.1161/STROKEAHA.120.033648. Epub 2021 Jun 17.
6
An aged immune system drives senescence and ageing of solid organs.衰老的免疫系统导致实体器官衰老和衰老。
Nature. 2021 Jun;594(7861):100-105. doi: 10.1038/s41586-021-03547-7. Epub 2021 May 12.
7
Does vascular endothelial dysfunction play a role in physical frailty and sarcopenia? A systematic review.血管内皮功能障碍在身体虚弱和肌肉减少症中起作用吗?一项系统综述。
Age Ageing. 2021 May 5;50(3):725-732. doi: 10.1093/ageing/afaa237.
8
2021 ACC Expert Consensus Decision Pathway on Same-Day Discharge After Percutaneous Coronary Intervention: A Report of the American College of Cardiology Solution Set Oversight Committee.2021年经皮冠状动脉介入治疗后当日出院的美国心脏病学会专家共识决策路径:美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2021 Feb 16;77(6):811-825. doi: 10.1016/j.jacc.2020.11.013. Epub 2021 Jan 7.
9
Comparative Trends in Percutaneous Coronary Intervention in Japan and the United States, 2013 to 2017.2013 至 2017 年日本与美国经皮冠状动脉介入治疗的对比趋势。
J Am Coll Cardiol. 2020 Sep 15;76(11):1328-1340. doi: 10.1016/j.jacc.2020.07.037.
10
Representation of Older Adults in Cardiovascular Disease Trials Since the Inclusion Across the Lifespan Policy.自全生命周期纳入政策以来,心血管疾病试验中老年人的代表性。
JAMA Intern Med. 2020 Nov 1;180(11):1531-1533. doi: 10.1001/jamainternmed.2020.2750.

接受经皮冠状动脉介入治疗的老年稳定型缺血性心脏病患者的院内结局及再入院情况。

In-hospital outcomes and readmission in older adults treated with percutaneous coronary intervention for stable ischemic heart disease.

作者信息

Park Dae Yong, Hanna Jonathan M, Kadian Sumeet, Kadian Mannat, Jones W Schuyler, Damluji Abdulla Al, Kochar Ajar, Curtis Jeptha P, Nanna Michael G

机构信息

Department of Medicine, Cook County Health, Chicago, IL, USA.

Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.

出版信息

J Geriatr Cardiol. 2022 Sep 28;19(9):631-642. doi: 10.11909/j.issn.1671-5411.2022.09.006.

DOI:10.11909/j.issn.1671-5411.2022.09.006
PMID:36284680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9548058/
Abstract

BACKGROUND

Percutaneous coronary intervention (PCI) for stable ischemic heart disease (SIHD) in older adults requires a meticulous assessment of procedural risks and benefits, but contemporary data on outcomes in this population is lacking. Therefore, we examined the risk of near-term readmission, bleeding, and mortality in high-risk cohort of older adults undergoing inpatient PCI for SIHD.

METHODS

We analyzed the National Readmissions Database from 2017 to 2018 to identify index hospitalizations in which PCI was performed for SIHD. Patients were stratified into those ≥ 75 years old (older adults) and those < 75 years old. The primary outcome was 90-day readmission. Secondary outcomes included in-hospital mortality, hospital length of stay (LOS), and total hospital charge.

RESULTS

A total of 74,516 patients underwent inpatient PCI for SIHD, of whom 24,075 were older adults. Older adult patients had higher odds of in-hospital mortality (OR = 2.00, 95% CI: 1.68-2.38), intracranial hemorrhage (OR = 2.03, 95% CI: 1.24-3.34), and gastrointestinal hemorrhage (OR = 1.72, 95% CI: 1.43-2.07) during index hospitalization, with longer LOS and in-hospital charge. Older adults also experienced a higher hazard of 90-day readmission for any cause (HR = 1.61, 95% CI: 1.57-1.66) and cardiovascular causes (HR = 1.84, 95% CI: 1.77-1.91).

CONCLUSION

Older adults undergoing inpatient PCI for SIHD were at increased risk for in-hospital mortality, periprocedural morbidities, higher cost, and readmissions compared with younger adults. Understanding these differences may improve shared decision-making for patients with SIHD being considered for PCI.

摘要

背景

对老年稳定型缺血性心脏病(SIHD)患者进行经皮冠状动脉介入治疗(PCI)需要对手术风险和益处进行细致评估,但目前缺乏该人群治疗结果的相关数据。因此,我们研究了因SIHD接受住院PCI治疗的高危老年人群近期再入院、出血和死亡的风险。

方法

我们分析了2017年至2018年的国家再入院数据库,以确定因SIHD进行PCI治疗的索引住院病例。患者被分为年龄≥75岁(老年人)和年龄<75岁两组。主要结局是90天再入院。次要结局包括住院死亡率、住院时间(LOS)和总住院费用。

结果

共有74516例患者因SIHD接受住院PCI治疗,其中24075例为老年人。老年患者在索引住院期间发生院内死亡(OR = 2.00,95%CI:1.68 - 2.38)、颅内出血(OR = 2.03,95%CI:1.24 - 3.34)和胃肠道出血(OR = 1.72,95%CI:1.43 - 2.07)的几率更高,住院时间更长,住院费用更高。老年人因任何原因(HR = 1.61,95%CI:1.57 - 1.66)和心血管原因(HR = 1.84,95%CI:1.77 - 1.91)发生90天再入院的风险也更高。

结论

与年轻患者相比,因SIHD接受住院PCI治疗的老年人发生院内死亡、围手术期并发症、费用更高和再入院的风险增加。了解这些差异可能会改善考虑接受PCI治疗的SIHD患者的共同决策。